Daniel Bradbury - Aug 1, 2022 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role: Director
Signature: /s/ Greg Acosta, Attorney-in-fact
Stock symbol: CSTL
Transactions as of: Aug 1, 2022
Transactions value $: -$211,629
Form type: 4
Date filed: 8/3/2022, 04:57 PM
Previous filing: Jun 13, 2022
Next filing: Sep 6, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSTL	Common Stock	Sale	-$212K	-7.7K	-3.13%	$27.47	238K	Aug 1, 2022	By LLC	F1, F2, F3
holding	CSTL	Common Stock						830	Aug 1, 2022	Direct
holding	CSTL	Common Stock						97.8K	Aug 1, 2022	By Daniel Bradbury Irrecovable Descendant's Trust	F4
holding	CSTL	Common Stock						97.8K	Aug 1, 2022	By Annette Bradbury Irrecovable Descendant's Trust	F5

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC on June 8, 2022.
F2	This transaction was executed in multiple trades at prices ranging from $27.09 to $27.97, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4	Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F5	Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.